Hiddo J. Lambers Heerspink

Latest

• Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine
• A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes